Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' KALLENBERG CGM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 163 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. van de Loosdrecht, AA; Kalk, W; Bootsma, H; Henselmans, JML; Kraan, J; Kallenberg, CGM
      Simultaneous presentation of sarcoidosis and Sjogren's syndrome

      RHEUMATOLOGY
    2. Tervaert, JWC; Stegeman, CA; Kallenberg, CGM
      Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    3. Brons, RH; Kallenberg, CGM; Tervaert, JWC
      Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    4. van der Geld, YM; Limburg, PC; Kallenberg, CGM
      Proteinase 3, Wegener's autoantigen: from gene to antigen

      JOURNAL OF LEUKOCYTE BIOLOGY
    5. Stegeman, CA; Kallenberg, CGM
      Clinical aspects of primary vasculitis

      SPRINGER SEMINARS IN IMMUNOPATHOLOGY
    6. Limburg, PC; Kallenberg, CGM
      Antinuclear antibody screening in this new millennium: Farewell to the microscope? Comment on the article

      SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    7. Bijl, M; Limburg, PC; Kallenberg, CGM
      New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis

      NETHERLANDS JOURNAL OF MEDICINE
    8. van der Geld, YM; Simpelaar, A; van der Zee, R; Tervaert, JWC; Stegeman, CA; Limburg, PC; Kallenberg, CGM
      Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: Epitope analysis using synthetic peptides

      KIDNEY INTERNATIONAL
    9. Heeringa, P; Bijl, M; de Jager-Krikken, A; Zandvoort, A; Dijkstra, G; Moshage, H; Tervaert, JWC; Tiebosch, ATMG; Kallenberg, CGM; van Goor, H
      Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosis

      JOURNAL OF PATHOLOGY
    10. Boomsma, MM; Stegeman, CA; Oost-Kort, WW; Kallenberg, CGM; Moguilevsky, N; Limburg, PC; Tervaert, JWC
      Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis

      JOURNAL OF IMMUNOLOGICAL METHODS
    11. Bijl, M; Horst, G; Limburg, PC; Kallenberg, CGM
      Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    12. Bijl, M; Horst, G; Limburg, PC; Kallenberg, CGM
      Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    13. Bijl, M; Horst, G; Limburg, PC; Kallenberg, CGM
      Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus

      ANNALS OF THE RHEUMATIC DISEASES
    14. Brons, RH; de Jong, MCJM; de Boer, NK; Stegeman, CA; Kallenberg, CGM; Tervaert, JWC
      Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis

      ANNALS OF THE RHEUMATIC DISEASES
    15. Kalk, WWI; Vissink, A; Spijkervet, FKL; Bootsma, H; Kallenberg, CGM; Amerongen, AVN
      Sialometry and sialochemistry: diagnostic tools for Sjogren's syndrome

      ANNALS OF THE RHEUMATIC DISEASES
    16. Eijkhout, HW; van der Meer, JWM; Kallenberg, CGM; Weening, RS; van Dissel, JT; Sanders, LAM; Strengers, PFW; Nienhuis, H; Schellekens, PTA
      The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia - A randomized, double-blind, multicenter crossover trial

      ANNALS OF INTERNAL MEDICINE
    17. Hoekstra, PJ; Bijzet, J; Limburg, PC; Steenhuis, MP; Troost, PW; Oosterhoff, MD; Korf, J; Kallenberg, CGM; Minderaa, RB
      Elevated D8/17 expression on B lymphocytes, a marker of rheumatic fever, measured with flow cytometry in tic disorder patients

      AMERICAN JOURNAL OF PSYCHIATRY
    18. Kallenberg, CGM; Tervaert, JWC
      New treatments of ANCA-associated vasculitis

      SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
    19. Hewins, P; Tervaert, JWC; Savage, COS; Kallenberg, CGM
      Is Wegener's granulomatosis an autoimmune disease?

      CURRENT OPINION IN RHEUMATOLOGY
    20. Kobold, ACM; Tulleken, JE; Zijlstra, JG; Sluiter, W; Hermans, J; Kallenberg, CGM; Tervaert, JWC
      Leukocyte activation in sepsis; correlations with disease state and mortality

      INTENSIVE CARE MEDICINE
    21. Roozendaal, C; de Jong, MA; van den Berg, AP; van Wijk, RT; Limburg, PC; Kallenberg, CGM
      Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases

      JOURNAL OF HEPATOLOGY
    22. Franssen, CFM; Stegeman, CA; Kallenberg, CGM; Gans, ROB; de Jong, PE; Hoorntje, SJ; Tervaert, JWC
      Antiproteinase 3-and antimyeloperoxidase-associated vasculitis

      KIDNEY INTERNATIONAL
    23. Van der Geld, YM; Huitema, MG; Franssen, CFM; Van der Zee, R; Limburg, PC; Kallenberg, CGM
      In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG)

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    24. Brons, RH; Bakker, HI; Van Wijk, RT; Van Dijk, NW; Kobold, ACM; Limburg, PC; Manson, WL; Kallenberg, CGM; Tervaert, JWC
      Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    25. Boomsma, MM; Stegeman, CA; van der Leij, MJ; Oost, W; Hermans, J; Kallenberg, CGM; Limburg, PC; Tervaert, JWC
      Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels - A prospective study

      ARTHRITIS AND RHEUMATISM
    26. Dijstelbloem, HM; Bijl, M; Fijnheer, R; Scheepers, RHM; Oost, WW; Jansen, MD; Sluiter, WJ; Limburg, PC; Derksen, RHWM; van de Winkel, JGJ; Kallenberg, CGM
      Fc gamma receptor polymorphisms in systemic lupus erythematosus - Association with disease and in vivo clearance of immune complexes

      ARTHRITIS AND RHEUMATISM
    27. Heeringa, P; van Goor, H; Itoh-Lindstrom, Y; Maeda, N; Falk, RJ; Assmann, KJM; Kallenberg, CGM; Jennette, JC
      Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis

      AMERICAN JOURNAL OF PATHOLOGY
    28. Roozendaal, C; Pogany, K; Hummel, EJ; Horst, G; Dijkstra, G; Nelis, GF; Limburg, PC; Kleibeuker, JH; Kallenberg, CGM
      Titres of anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    29. Foucher, P; Heeringa, P; Petersen, AH; Huitema, MG; Brouwer, E; Tervaert, JWC; Prop, J; Camus, P; Weening, FJ; Kallenberg, CGM
      Antimyeloperoxidase-associated lung disease - An experimental model

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    30. Franssen, CFM; Huitema, MG; Kobold, ACM; Oost-Kort, WW; Limburg, PC; Tiebosch, A; Stegeman, CA; Kallenberg, CGM; Tervaert, JWC
      In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    31. Kobold, ACM; van Wijk, RT; Franssen, CFM; Molema, G; Kallenberg, CGM; Tervaert, JWC
      In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    32. van Lopik, T; Bijl, M; Hart, M; Boeije, L; Gesner, T; Creasy, AA; Kallenberg, CGM; Aarden, LA; Smeenk, RJT; Smeenk, JT
      Patients with systemic lupus erythematosus with high plasma levels of sFasrisk relapse

      JOURNAL OF RHEUMATOLOGY
    33. Haveman, JW; Kobold, ACM; Tervaert, JWC; van den Berg, AP; Tulleken, JE; Kallenberg, CGM; The, TH
      The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment

      NETHERLANDS JOURNAL OF MEDICINE
    34. Roozendaal, C; Kallenberg, CGM
      Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases

      HEPATO-GASTROENTEROLOGY
    35. Popa, ER; Stegeman, CA; Bos, NA; Kallenberg, CGM; Tervaert, JWC
      Differential B- and T-cell activation in Wegener's granulomatosis

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    36. Roozendaal, C; Pogany, K; Horst, G; Jagt, TG; Kleibeuker, JH; Nelis, GF; Limburg, PC; Kallenberg, CGM
      Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases?

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    37. de Jong, BM; Pruim, J; Sinnige, LGF; Beintema, KD; Spronk, PE; Bootsma, H; Kallenberg, CGM; van Zomeren, AH; Haaxma-Reiche, H
      Regional specific changes of cerebral metabolism in systemic lupus erythematosus identified by positron emission tomography

      EUROPEAN NEUROLOGY
    38. Van Der Geld, YM; Limburg, PC; Kallenberg, CGM
      Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    39. Roozendaal, C; Kallenberg, CGM
      Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    40. Dijstelbloem, HM; Scheepers, RHM; Oost, WW; Stegeman, CA; van der Pol, WL; Sluiter, WJ; Kallenberg, CGM; van de Winkel, JGJ; Tervaert, JWC
      Fc gamma receptor polymorphisms in Wegener's granulomatosis - Risk factorsfor disease relapse

      ARTHRITIS AND RHEUMATISM
    41. Kallenberg, CGM; Heeringa, P; Tervaert, JWC
      Are antineutrophil cytoplasmic antibodies pathogenic in wegener's granulomatosis? Lessons from in vitro and in vivo experimental findings

      DECADE OF AUTOIMMUNITY
    42. SPRONK PE; BOOTSMA H; KALLENBERG CGM
      ANTI-DNA ANTIBODIES AS EARLY PREDICTOR FOR DISEASE EXACERBATIONS IN SLE - GUIDELINE FOR TREATMENT

      Clinical reviews in allergy and immunology
    43. FRANSSEN CFM; STEGEMAN CA; OOSTKORT WW; KALLENBERG CGM; LIMBURG PC; TIEBOSCH A; DEJONG PE; TERVAERT JWC
      DETERMINANTS OF RENAL OUTCOME IN ANTI-MYELOPEROXIDASE-ASSOCIATED NECROTIZING CRESCENTIC GLOMERULONEPHRITIS

      Journal of the American Society of Nephrology
    44. KALLENBERG CGM; HEERINGA P
      PATHOGENESIS OF VASCULITIS

      Lupus
    45. KALLENBERG CGM
      AUTOANTIBODIES TO MYELOPEROXIDASE - CLINICAL AND PATHOPHYSIOLOGICAL SIGNIFICANCE

      Journal of molecular medicine
    46. TERVAERT JWC; STEGEMAN CA; MANSON WL; KALLENBERG CGM; JOHNSON WM
      STAPHYLOCOCCUS-AUREUS (SA) SUPERANTIGENS - A RISK FACTOR FOR DISEASE REACTIVATION IN WEGENERS GRANULOMATOSIS (WG)

      The FASEB journal
    47. KOBOLD ACM; KALLENBERG CGM; TERVAERT JWC
      LEUKOCYTE MEMBRANE EXPRESSION OF PROTEINASE-3 CORRELATES WITH DISEASE-ACTIVITY IN PATIENTS WITH WEGENERS GRANULOMATOSIS

      British journal of rheumatology (Print)
    48. HEERINGA P; BROUWER E; TERVAERT JWC; WEENING JJ; KALLENBERG CGM
      ANIMAL-MODELS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS

      Kidney international
    49. HEERINGA P; VANGOOR H; MOSHAGE H; KLOK PA; HUITEMA MG; DEJAGER A; SCHEP AJ; KALLENBERG CGM
      EXPRESSION OF INOS, ENOS, AND PEROXYNITRITE-MODIFIED PROTEINS IN EXPERIMENTAL ANTIMYELOPEROXIDASE ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS

      Kidney international
    50. ROOZENDAAL C; DEWIT AWMV; HAAGSMA EB; HORST G; SCHWARZE C; PETER HH; KLEIBEUKER JH; TERVAERT JWC; LIMBURG PC; KALLENBERG CGM
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS - TARGET ANTIGENS AND CLINICAL ASSOCIATIONS

      Gastroenterology
    51. ROOZENDAAL C; HUMMEL EJ; DEJONG MA; KLEIBEUKER JH; VANDENBERG AP; LIMBURG PC; KALLENBERG CGM
      ANTIBODIES AGAINST MONOCYTES IN INFLAMMATORY BOWEL AND AUTOIMMUNE LIVER-DISEASES

      Gastroenterology
    52. ROOZENDAAL C; ZHAO MH; HORST G; LOCKWOOD CM; KLEIBEUKER JH; LIMBURG PC; NELIS GF; KALLENBERG CGM
      CATALASE AND ALPHA-ENOLASE - 2 NOVEL GRANULOCYTE AUTOANTIGENS IN INFLAMMATORY BOWEL DISEASES

      Gastroenterology
    53. KOBOLD ACM; ZIJLSTRA JG; KOENE HR; DEHAAS M; KALLENBERG CGM; TERVAERT JWC
      LEVELS OF SOLUBLE FC-GAMMA-RIII CORRELATE WITH DISEASE SEVERITY IN SEPSIS

      Clinical and experimental immunology
    54. ROOZENDAAL C; ZHAO MH; HORST G; LOCKWOOD CM; KLEIBEUKER JH; LIMBURG PC; NELIS GF; KALLENBERG CGM
      CATALASE AND ALPHA-ENOLASE - 2 NOVEL GRANULOCYTE AUTOANTIGENS IN INFLAMMATORY BOWEL-DISEASE (IBD)

      Clinical and experimental immunology
    55. Kobold, ACM; Mesander, G; Stegeman, CA; Kallenberg, CGM; Tervaert, JWC
      Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides?

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    56. KOENE HR; KLEIJER M; SWAAK AJG; SULLIVAN KE; BIJL M; PETRI MA; KALLENBERG CGM; ROOS D; VONDEMBORNE AEGK; DEHAAS M
      THE FC-GAMMA-RIIIA-158F ALLELE IS A RISK FACTOR FOR SYSTEMIC LUPUS-ERYTHEMATOSUS

      Arthritis and rheumatism
    57. ROOZENDAAL C; VANMILLEGENDEWIT AWM; HAAGSMA EB; HORST G; SCHWARZE C; PETER HH; KLEIBEUKER JH; TERVAERT JWC; LIMBURG PC; KALLENBERG CGM
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS - DEFINED SPECIFICITIES MAY BE ASSOCIATED WITH DISTINCT CLINICAL-FEATURES

      The American journal of medicine
    58. GEORGE J; LEVY Y; KALLENBERG CGM; SHOENFELD Y
      INFECTIONS AND WEGENERS GRANULOMATOSIS - A CAUSE AND EFFECT RELATIONSHIP

      Quarterly Journal of Medicine
    59. KALLENBERG CGM
      VASCULITIS AND THE KIDNEY

      Kidney & blood pressure research
    60. TERVAERT JWC; STEGEMAN CA; MANSON WL; KALLENBERG CGM; JOHNSON WM
      STAPHYLOCOCCUS-AUREUS (SA) SUPERANTIGENS - A RISK FACTOR FOR DISEASE REACTIVATION IN WEGENERS GRANULOMATOSIS (WG)

      Journal of the American Society of Nephrology
    61. FRANSSEN CFM; STEGEMAN CA; DEJONG PE; KALLENBERG CGM; TERVAERT JWC
      KIDNEY SURVIVAL IN PATIENTS WITH ANTIMYELOPEROXIDASE (MPO) ASSOCIATEDGLOMERULONEPHRITIS (GN) IS RELATED TO THE SEVERITY OF PROTEINURIA

      Journal of the American Society of Nephrology
    62. POPA ER; BOS NA; STEGEMAN CA; KALLENBERG CGM; TERVAERT JWC
      SKEWED TCR V-BETA USAGE IN WEGENERS GRANULOMATOSIS SUGGESTS STIMULATION BY SUPERANTIGENS

      Journal of the American Society of Nephrology
    63. POPA ER; STEGEMAN CA; BOS NA; KALLENBERG CGM; TERVAERT JWC
      T-LYMPHOCYTE BUT NOT BETA-LYMPHOCYTE ACTIVATION IN WEGENERS GRANULOMATOSIS PERSISTS DURING REMISSION

      Journal of the American Society of Nephrology
    64. KALLENBERG CGM
      LABORATORY FINDINGS IN THE VASCULITIDES

      Bailliere's clinical rheumatology
    65. STEGEMAN CA; TERVAERT JWC; KALLENBERG CGM
      COTRIMOXAZOLE AND WEGENERS GRANULOMATOSIS - MORE THAN A COINCIDENCE

      Nephrology, dialysis, transplantation
    66. STEGEMAN CA; TERVAERT JWC; KALLENBERG CGM
      SULFONAMIDES IN VASCULITIDES - WHICH MECHANISM - REPLY

      Nephrology, dialysis, transplantation
    67. VANBRUGGEN MCJ; KRAMERS C; WALGREEN B; ELEMA JD; KALLENBERG CGM; VANDENBORN J; SMEENK RJT; ASSMANN KJM; MULLER S; MONESTIER M; BERDEN JHM
      NUCLEOSOMES AND HISTONES ARE PRESENT IN GLOMERULAR DEPOSITS IN HUMAN LUPUS NEPHRITIS

      Nephrology, dialysis, transplantation
    68. HEERINGA P; VANGOOR H; MOSHAGE H; KLOK PA; KALLENBERG CGM
      EXPRESSION OF INOS, ENOS, AND PEROXYNITRITE MODIFIED PROTEINS IN EXPERIMENTAL ANTIMYELOPEROXIDASE ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS (NCGN)

      Kidney international
    69. FRANSSEN CFM; STEGEMAN CA; OOSTKORT W; KALLENBERG CGM; COHEN JW
      PERSISTENTLY HIGH-LEVELS OF ANTIBODIES AGAINST MYELOPEROXIDASE (MPO) ARE PREDICTIVE OF POOR OUTCOME IN PATIENTS WITH ANTI-MPO ASSOCIATED GLOMERULONEPHRITIS

      Kidney international
    70. JAYNE DRW; RASMUSSEN N; ABRAMOWICZ D; TESAR V; RASMUSSEN N; PETERSEN J; JUHL BR; WIIK A; GRONHAGENRISKA C; GUILLEVIN L; LHOTE F; LANDAIS P; LESAVRE P; VANHILLE P; ANDRASSY K; DEGROOT K; GROSS WL; VANDERWOUDE F; BOKI KA; TERVAERT JWC; KALLENBERG CGM; VANES LA; HERMANS J; SIEGERT C; HAGEN EC; FEIGHERY CF; GREGORINI G; FERRARIO F; SINICO RA; DADONIENE J; VASCONCELOS C; MIRAPEIX E; HEIGL Z; PETTERSSON EE; WESTMAN KWA; BACON PA; SAVAGE COS; JAYNE DRW; LOCKWOOD CM; LUQMANI RA; GASKIN G; PUSEY CD; SPECKS U
      TREATMENT OF ANTINEUTROPHIL CYTOPLASM AUTOANTIBODY-ASSOCIATED SYSTEMIC VASCULITIS - INITIATIVES OF THE EUROPEAN-COMMUNITY SYSTEMIC VASCULITIS CLINICAL-TRIALS STUDY-GROUP

      Mayo Clinic proceedings
    71. KALLENBERG CGM
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AND THE ENDOTHELIUM - MANY WAYSTO VASCULITIS

      European journal of clinical investigation
    72. HARMSEN MC; HEERINGA P; VANDERGELD YM; HUITEMA MG; KLIMP A; TIRAN A; KALLENBERG CGM
      RECOMBINANT PROTEINASE-3 (WREGENERS ANTIGEN) EXPRESSED IN PICHIA-PASTORIS IS FUNCTIONALLY ACTIVE AND IS RECOGNIZED BY PATIENT SERA

      Clinical and experimental immunology
    73. KOENE HR; KLEIJER M; SWAAK AJG; SULLIVAN KE; BIJL M; PETRI MA; KALLENBERG CGM; ROOS D; VONDEMBORNE AEGK; DEHAAS M
      THE FC-GAMMA-RIIIA-158F IS A RISK FACTOR FOR SYSTEMIC LUPUS-ERYTHEMATOSUS

      Blood
    74. BOOTSMA H; DERKSEN RHWM; JAEGERS SMHJ; SPRONK PE; BIJL M; KATER L; KALLENBERG CGM
      USEFULNESS OF THE SLICC ACR DAMAGE INDEX IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS/

      Arthritis and rheumatism
    75. BILL M; VANLOPIK T; LIMBURG PC; AARDEN LA; SMEENK RJT; KALLENBERG CGM
      FLUCTUATING LEVELS OF SERUM-SOLUBLE FAS IN RELATION TO DISEASE-ACTIVITY AND LYMPHOCYTE-ACTIVATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS

      Arthritis and rheumatism
    76. KALLENBERG CGM; BOOTSMA H; SPRONK PE; TERBORG EJ; DERKSEN RHWM; KATER L
      LABORATORY TESTS AS PREDICTORS OF FLARES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - COMMENT

      Arthritis and rheumatism
    77. BOOTSMA H; SPRONK PE; TERBORG EJ; HUMMEL EJ; DEBOER G; LIMBURG PC; KALLENBERG CGM
      THE PREDICTIVE VALUE OF FLUCTUATIONS IN IGM AND IGG CLASS ANTI-DSDNA ANTIBODIES FOR RELAPSES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE LONG-TERM OBSERVATION

      Annals of the Rheumatic Diseases
    78. HEERINGA P; FOUCHER P; KLOK PA; HUITEMA MG; TERVAERT JWC; WEENING JJ; KALLENBERG CGM
      SYSTEMIC INJECTION OF PRODUCTS OF ACTIVATED NEUTROPHILS AND H2O2 IN MYELOPEROXIDASE-IMMUNIZED RATS LEADS TO NECROTIZING VASCULITIS IN THE LUNGS AND GUT

      The American journal of pathology
    79. TERVAERT JWC; STEGEMAN CA; KALLENBERG CGM
      SERIAL ANCA TESTING IS USEFUL IN MONITORING DISEASE-ACTIVITY OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIDES

      Sarcoidosis vasculitis and diffuse lung diseases
    80. KALLENBERG CGM; STEGEMAN CA; TERVAERT JWC
      STAPHYLOCOCCUS-AUREUS, TRIMETHOPRIM-SULFAMETHOXAZOLE, AND WEGENERS GRANULOMATOSIS

      Sarcoidosis vasculitis and diffuse lung diseases
    81. HEERINGA P; KLOK PA; HUITEMA MG; VANDENBORN J; WEENING JJ; KALLENBERG CGM
      AUTOANTIBODIES TO MYELOPEROXIDASE AGGRAVATE MILD IMMUNE-MEDIATED GLOMERULAR INJURY IN THE RAT

      Journal of the American Society of Nephrology
    82. HEERINGA P; VANGOOR H; MOSHAGE H; KALLENBERG CGM
      EXPRESSION OF INOS, ENOS, AND PEROXYNITRITE MODIFIED PROTEINS IN EXPERIMENTAL ANTI MYELOPEROXIDASE ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS

      Journal of the American Society of Nephrology
    83. FRANSSEN CFM; STEGEMAN CA; OOSTKORT WW; KALLENBERG CGM; TERVAERT JWC
      PROGNOSTIC FACTORS IN ANTIMYELOPEROXIDASE (MPO) ASSOCIATED GLOMERULONEPHRITIS (GN)

      Journal of the American Society of Nephrology
    84. TERVAERT JWC; BAKKER HI; GJALTEMAVANBUITEN L; HEERINGA P; MANSON WL; KALLENBERG CGM
      STAPHYLOCOCCAL ACID-PHOSPHATASE BINDS TO CULTURED ENDOTHELIAL-CELLS AND TO THE GLOMERULAR CAPILLARY WALL IN-VIVO

      Journal of the American Society of Nephrology
    85. KOBOLD ACM; MESANDER G; KALLENBERG CGM; TERVAERT JWC
      INCREASED EXPRESSION OF LEUKOCYTE ADHESION MOLECULES ON CIRCULATING LEUKOCYTES IN ANTINEUTROPHIL CYTOPLASMIC ASSOCIATED (ANCA) VASCULITIS

      The FASEB journal
    86. KALLENBERG CGM
      TREATMENT OF WEGENER GRANULOMATOSIS - NEW HORIZONS

      Clinical and experimental rheumatology
    87. BOOTSMA H; SPRONK PE; HUMMEL EJ; DEBOER G; TERBORG EJ; LIMBURG PC; KALLENBERG CGM
      ANTI-DOUBLE STRANDED DNA ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS -DETECTION AND CLINICAL RELEVANCE OF IGM-CLASS ANTIBODIES

      Scandinavian journal of rheumatology
    88. SPRONK PE; BOOTSMA H; HORST G; HUITEMA MG; LIMBURG PC; TERVAERT JWC; KALLENBERG CGM
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS

      British journal of rheumatology
    89. DEJONG BM; PRUIM J; SINNIGE LGF; BEINTEMA KD; KALLENBERG CGM; HAAXMAREICHE H
      EVIDENCE FOR REDUCED PREMOTOR CORTEX METABOLISM AND INCREASED BASAL GANGLIA FLUORODEOXYGLUCOSE (FDG) UPTAKE IN CEREBRAL SYSTEMIC LUPUS

      The Journal of nuclear medicine
    90. FRANSSEN CFM; TERVAERT JWC; STEGEMAN CA; KALLENBERG CGM
      C-ANCA AS A MARKER OF WEGENERS DISEASE

      Lancet
    91. STEGEMAN CA; TERVAERT JWC; KALLENBERG CGM
      COTRIMOXAZOLE IN WEGENERS GRANULOMATOSIS - REPLY

      The New England journal of medicine
    92. STEGEMAN CA; TERVAERT JWC; DEJONG PE; KALLENBERG CGM
      TRIMETHOPRIM-SULFAMETHOXAZOLE (COTRIMOXAZOLE) FOR THE PREVENTION OF RELAPSES OF WEGENERS GRANULOMATOSIS

      The New England journal of medicine
    93. HAGEN EC; ANDRASSY K; CSERNOK E; DAHA MR; GASKIN G; GROSS WL; HANSEN B; HEIGL Z; HERMANS J; JAYNE D; KALLENBERG CGM; LESAVRE P; LOCKWOOD CM; LUDEMANN J; MASCARTLEMONE F; MIRAPEIX E; PUSEY CD; RASMUSSEN N; SINICO RA; TZIOUFAS A; WIESLANDER J; WIIK A; VANDERWOUDE FJ
      DEVELOPMENT AND STANDARDIZATION OF SOLID-PHASE ASSAYS FOR THE DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) - A REPORT ON THE 2ND-PHASE OF AN INTERNATIONAL COOPERATIVE STUDY ON THE STANDARDIZATION OF ANCA ASSAYS

      Journal of immunological methods
    94. KALLENBERG CGM
      VASCULITIS 1995 - NEW CONCEPTS IN PATHOPHYSIOLOGY

      Israel journal of medical sciences
    95. ROOZENDAAL C; HORST G; POGANY K; BROEKROELOFS J; KLEIBEUKER JH; NELIS GF; LIMBURG PC; KALLENBERG CGM
      PREVALENCE AND CHARACTERIZATION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN INFLAMMATORY BOWEL DISEASES

      Gastroenterology
    96. HEERINGA P; VANDENBORN J; BROUWER E; DOLMAN KM; KLOK PA; HUITEMA MG; LIMBURG PC; BAKKER MAH; BERDEN JHM; DAHA MR; KALLENBERG CGM
      ELASTASE, BUT NOT PROTEINASE-3 (PR3), INDUCES PROTEINURIA ASSOCIATED WITH LOSS OF GLOMERULAR-BASEMENT-MEMBRANE HEPARAN-SULFATE AFTER IN-VIVO RENAL PERFUSION IN RATS

      Clinical and experimental immunology
    97. SPRONK PE; HORST G; VANDERGUN BTF; LIMBURG PC; KALLENBERG CGM
      ANTI-DSDNA PRODUCTION COINCIDES WITH CONCURRENT B-CELL AND T-CELL ACTIVATION DURING DEVELOPMENT OF ACTIVE DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)

      Clinical and experimental immunology
    98. HEERINGA P; FOUCHER P; KLOK PA; HUITEMA MG; TERVAERT JWC; KALLENBERG CGM
      SYSTEMIC INJECTION OF MYELOPEROXIDASE IN MYELOPEROXIDASE IMMUNIZED BROWN-NORWAY RATS

      Arthritis and rheumatism
    99. BOOTSMA H; SPRONK PE; LIMBURG PC; MEYLING FHJG; KATER L; DERKSEN RHWM; KALLENBERG CGM
      COMPARISON OF SENSITIVITY TO CHANGE OF 2 CLINICAL MEASURES OF LUPUS DISEASE-ACTIVITY - A LONGITUDINAL PROSPECTIVE-STUDY

      Arthritis and rheumatism
    100. KRAMERS C; VANBRUGGEN MCJ; WALGREEN B; ELEMA JD; KALLENBERG CGM; VANDEBORN J; ASSMANN KJM; MULLER S; MONESTIER M; BERDEN JHM
      NUCLEOSOMES AND HISTONES ARE PRESENT IN GLOMERULAR DEPOSITS IN HUMAN LUPUS NEPHRITIS

      Journal of the American Society of Nephrology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 03:26:13